Andrew Rowland
Impact in
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 1%
- Drug Transport and Resistance Mechanisms
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
Papers in
- Pharmacology 40
- Pharmacogenetics and Drug Metabolism 38
- Oncology 83
- Drug Transport and Resistance Mechanisms 28
- Cancer Immunotherapy and Biomarkers 19
- Colorectal Cancer Treatments and Studies 15
- HER2/EGFR in Cancer Research 12
- Cancer Treatment and Pharmacology 9
- Co-authors
- John O. MinersMichael J. SorichPeter I. MackenzieGanessan KichenadasseRoss A. McKinnonAshley M. HopkinsChristos S. KarapetisMichael D. Wiese
- Journals
- Drug Metabolism and Disposition (13 papers)Clinical Pharmacology & Therapeutics (4 papers)Expert Opinion on Drug Metabolism & Toxicology (4 papers)British Journal of Clinical Pharmacology (4 papers)European Journal of Clinical Pharmacology (4 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Andrew Rowland
139 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Pharmacology 1.4k
- Oncology 2.4k
- Cancer Research 544
- Health Informatics 38
- Pathology and Forensic Medicine 453
Countries citing papers authored by Andrew Rowland
This map shows the geographic impact of Andrew Rowland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Rowland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Rowland more than expected).
Fields of papers citing papers by Andrew Rowland
This network shows the impact of papers produced by Andrew Rowland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Rowland. The network helps show where Andrew Rowland may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Rowland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 11 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 9 | |
| 6 | 2021 | 51 | |
| 7 | 2021 | 26 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 6 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 7 | |
| 13 | 2020 | 30 | |
| 14 | 2020 | 30 | |
| 15 | 2020 | 29 | |
| 16 | 2019 | 73 | |
| 17 | 2018 | 62 | |
| 18 | 2018 | 8 | |
| 19 | 2016 | 12 | |
| 20 | Testing for familial cancer susceptibility gene mutations | 2003 | 1 |
About Andrew Rowland
Andrew Rowland is a scholar working on Pharmacology, Oncology, Health Informatics, Transplantation and Cancer Research, having authored 144 papers that have together received 4.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (38 papers), Drug Transport and Resistance Mechanisms (28 papers), Cancer Immunotherapy and Biomarkers (19 papers), Lung Cancer Treatments and Mutations (19 papers), Colorectal Cancer Treatments and Studies (15 papers), HER2/EGFR in Cancer Research (12 papers), Extracellular vesicles in disease (12 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Pharmacology (1.4k citations), Oncology (2.4k citations), Cancer Research (544 citations), Health Informatics (38 citations) and Pathology and Forensic Medicine (453 citations). Andrew Rowland has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include John O. Miners, Michael J. Sorich, Peter I. Mackenzie, Ganessan Kichenadasse, Ross A. McKinnon, Ashley M. Hopkins, Christos S. Karapetis, Michael D. Wiese, Kathleen Knights and Arduino A. Mangoni. Their work appears in journals such as Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, Expert Opinion on Drug Metabolism & Toxicology, British Journal of Clinical Pharmacology and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.